Teleflex (BSP:T1FX34) Total Liabilities: R$19,342 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:T1FX34 Teleflex Inc BSP:T1FX34
14 GF Score
Price R$69.78
GF Value R$94.33
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Teleflex Total Liabilities?

Teleflex BSP:T1FX34 +2.87% 14 Total Liabilities is R$19,342 Mil as of Mar. 2026. GuruFocus rates BSP:T1FX34 with a GF Score™ of 14/100 and a GF Value™ of R$94.33 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Teleflex's Total Liabilities for the quarter that ended in Mar. 2026 was R$19,342 Mil.

Teleflex's quarterly Total Liabilities declined from Sep. 2025 (R$21,720.56 Mil) to Dec. 2025 (R$20,854.26 Mil) and declined from Dec. 2025 (R$20,854.26 Mil) to Mar. 2026 (R$19,342.02 Mil).

Teleflex's annual Total Liabilities increased from Dec. 2023 (R$15,148.02 Mil) to Dec. 2024 (R$17,203.44 Mil) and increased from Dec. 2024 (R$17,203.44 Mil) to Dec. 2025 (R$20,854.26 Mil).

Teleflex Total Liabilities Historical Data

* Premium members only.

The historical data trend for Teleflex's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex Total Liabilities Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,626.18 15,243.63 15,148.02 17,203.44 20,854.26

Teleflex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,666.58 17,371.39 21,720.56 20,854.26 19,342.02
BSP:T1FX34
14GF Score
Teleflex Inc BSP:T1FX34
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teleflex Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Teleflex's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4157.385+(14324.808+1369.583
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+1002.479+0+0)
=20,854

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=37902.052-17047.797
=20,854

Teleflex's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3807.405+(13505.902+1142.668
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+886.046+0+0)
=19,342

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=35472.387-16130.367
=19,342

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of R$19,342 Mil mean?
Teleflex (BSP:T1FX34) has a Total Liabilities of R$19,342 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Teleflex and its competitors.
Is Teleflex's Total Liabilities too high?
Teleflex's current Total Liabilities is R$19,342 Mil. Overall, Teleflex has a GF Score™ of 14/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's Total Liabilities compare to STVN and AVTR?
Teleflex's Total Liabilities of R$19,342 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Teleflex and its competitors. Teleflex's current Total Liabilities is R$19,342 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (BSP:T1FX34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$94.33, compared to a current price of R$69.78 — trading 26% below its estimated fair value. The current Total Liabilities is R$19,342 Mil. Teleflex's overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Teleflex (BSP:T1FX34), the current Total Liabilities is R$19,342 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (BSP:T1FX34) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of R$69.78 is trading 26% below its estimated GF Value™ of R$94.33. GuruFocus considers Teleflex to be Modestly Undervalued.

Key valuation signals for BSP:T1FX34:

  • Total Liabilities: R$19,342 Mil
  • GF Value™: R$94.33 vs. price of R$69.78 (26% below fair value)
  • GF Score™: 14/100 with 7 warning signs

No single metric tells the full story. See the BSP:T1FX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teleflex Business Description

Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
14GF Score

Get the complete analysis for BSP:T1FX34

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$69.78
Price
R$94.33
GF Value